The effect of magnesium sulfate on maternal serum electrolytes and parathyroid hormone in pre-eclampsia

被引:2
|
作者
Farahani, Masoumeh [1 ]
Sharifinejad, Niusha [2 ]
Hashemnejad, Maryam [1 ]
Mashak, Banafsheh [3 ]
Mahboubipour, Hamid [4 ]
Farahani, Mahnaz [5 ]
Rastad, Hadith [2 ]
Nirouei, Matineh [5 ]
机构
[1] Alborz Univ Med Sci, Dept Obstet & Gynecol, Karaj, Iran
[2] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran
[3] Alborz Univ Med Sci, Sch Med, Dept Anesthesiol, Karaj, Iran
[4] Alborz Univ Med Sci, Gastroenterol, Karaj, Iran
[5] Alborz Univ Med Sci, Karaj, Iran
关键词
calcium; magnesium sulfate; parathyroid hormone; phosphorus; pre-eclampsia; serum electrolytes; HYPOCALCEMIA; THERAPY; CALCIUM; HYPERKALEMIA; HYPERMAGNESEMIA; EXCRETION; INFUSION;
D O I
10.1002/ijgo.14296
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective To evaluate possible interactions of magnesium sulfate-the drug of choice in the management of pre-eclampsia/eclampsia-in response to a few case reports that revealed maternal electrolyte disturbances, especially symptomatic changes, following magnesium sulfate administration in pre-eclampsia. Methods Prospectively, women with pre-eclampsia were given 4 g of intravenous magnesium sulfate followed by a 2 g/h infusion up to 24 h after delivery. Sequential blood samples were drawn from each patient and used to measure the serum levels of sodium, potassium, calcium, phosphorus, magnesium, and parathyroid hormone. Results A total of 30 pregnant women with pre-eclampsia were evaluated. They were aged between 20 and 41 years with median gestational age of 37.6 (interquartile range 35.4-38.9) weeks. Only five patients reached the therapeutic window of magnesium in at least one of our measuring intervals during magnesium sulfate infusion. Plasma magnesium concentrations increased significantly during magnesium sulfate administration and dropped during the next 12 and 24 h after infusion discontinuation (P < 0.05). Fifteen of 30 (50%) patients developed asymptomatic hypocalcemia, mainly at hour 24 of infusion. Negative moderate correlations were detected between the calcium and magnesium concentrations at 12 and 24 hours of infusion (rho = -0.390, P = 0.044 and rho = 0.315, P = 0.096, respectively). None of the patients with hypocalcemia reached the therapeutic level of magnesium or experienced parallel hyperphosphatemia. Eleven of 30 (36.6%) patients developed hyperphosphatemia mainly at 2 and 12 h of magnesium sulfate infusion. Conclusions Our study implies that magnesium sulfate could cause hypermagnesemia-induced hypocalcemia in women with pre-eclampsia, independent from parathyroid hormone. The negative correlations between calcium and magnesium concentrations could be indicative of dose-dependent associations between serum magnesium level and degree of hypocalcemia in our study.
引用
收藏
页码:938 / 943
页数:6
相关论文
共 50 条
  • [41] Serum markers for predicting pre-eclampsia
    Baumann, Marc U.
    Bersinger, Nick A.
    Surbek, Daniel V.
    MOLECULAR ASPECTS OF MEDICINE, 2007, 28 (02) : 227 - 244
  • [42] Serum biomarkers predictive of pre-eclampsia
    Anand, Swati
    Alvarez, Tanielle Mei Bench
    Johnson, W. Evan
    Esplin, M. Sean
    Merrell, Karen
    Porter, T. Flint
    Graves, Steven W.
    BIOMARKERS IN MEDICINE, 2015, 9 (06) : 563 - 575
  • [43] Effect of magnesium sulfate combined with labetalol on serum sFlt-1/PlGF ratio in patients with early-onset severe pre-eclampsia
    Wang, Ying
    Bao, Jing
    Peng, Min
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (06)
  • [44] Comparison of serum trace element levels in patients with or without pre-eclampsia
    Farzin, Leila
    Sajadi, Fattaneh
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (10): : 938 - 941
  • [45] Dietary intake of calcium, magnesium and zinc in women with pre-eclampsia and diabetes gestacional
    Dantas, Maryze Valeria Lima
    Nascimento, Fransoaine Graviel do
    Rocha, Vivianne de Sousa
    NUTRICION CLINICA Y DIETETICA HOSPITALARIA, 2016, 36 (03): : 130 - 137
  • [46] Maternal rubella immunity status and pre-eclampsia
    Lao, Terence T.
    Sahota, Daljit S.
    Law, Lai-Wa
    Leung, Tak-Yeung
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2017, 78 (01)
  • [47] Possible therapeutic effect of magnesium sulfate in pre-eclampsia by the down-regulation of placental tumor necrosis factor-alpha secretion
    Amash, Alaa
    Weintraub, Adi Y.
    Sheiner, Eyal
    Zeadna, Atef
    Huleihel, Mahmoud
    Holcberg, Gershon
    EUROPEAN CYTOKINE NETWORK, 2010, 21 (01) : 58 - 64
  • [48] Efficacy and safety of 12-hour versus 24-hour magnesium sulfate in management of patients with pre-eclampsia and eclampsia: a systematic review and meta-analysis
    Shaheen, Rahma Sameh
    Ismail, Rahma Abdelaziz
    Salama, Esraa Y.
    Korini, Sally Median
    Elsaeidy, Ahmed Saad
    BMC WOMENS HEALTH, 2024, 24 (01)
  • [49] Analysis on Clinical Outcomes of Low-Molecular Weight Heparin Combined with Magnesium Sulfate in Patients with Pre-Eclampsia
    Wang, Ningning
    Feng, Chun
    Sun, Minghe
    Pu, Ying
    IRANIAN JOURNAL OF PUBLIC HEALTH, 2022, 51 (05) : 1067 - 1075
  • [50] Maternal mortality due to pre-eclampsia/eclampsia in a state in Southern Brazil
    Muniz Nequer Soares, Vania
    de Souza, Kleyde Ventura
    Freygang, Tatiana Claumann
    Correa, Vanessa
    Saito, Maria Rialto
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2009, 31 (11): : 566 - 573